Venue and dates
September 14-16, 2012
Prague, Czech Republic
Jean-Michel Pawlotsky (former EASL Secretary General), France
Heiner Wedemeyer (former EASL Secretary General), Germany
Adrian Di Bisceglie (AASLD), USA
Jake Liang (AASLD President), USA
|Update: October, 1, 2012
EASL would like to thank everyone who attended for making the Prague Special Conference on Therapy of Hepatitis C: Clinical Application and Drug Development, an enormous success.
The European Association for the Study of the Liver (EASL), together with the American Association for the Study of Liver Diseases (AASLD), has decided to organise an exciting “Special Conference” dedicated to a timely topic: Therapy of Hepatitis C: Clinical Application and Drug Development.
We hope you will find this meeting of interest; during the two days of the conference, leading international experts involved in Hepatitis C, will highlight and address a series of lectures, but will also participate in interactive debates on hot topics. Case presentations and parallel interactive sessions will take place and space will be reserved for poster presentations of original works in the field.
This 2012 Special Conference will provide an opportunity to keep pace with the latest developments in this field. The programme has equally been designed to provide adequate time for discussion and networking.
Aims of the conference